← Eichor
Study identifier: NCT07206199 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Virtual Reality Exposure Therapy for Obsessive-Compulsive Disorder: Outpatients Trial

Condition: Obsessive-compulsive Disorder  ·  Sponsor: National Institute of Mental Health, Czech Republic

PhaseNA
Planned participants30
Who can joinAll sexes, 18 Years to 55 Years
Healthy volunteersNo

About this study

The aim of this study is to evaluate the efficacy of virtual reality exposure therapy (VRET) as a treatment for obsessive-compulsive disorder (OCD). This study focuses on patients receiving treatment in outpatient psychiatry or clinical psychology settings, utilizing a within-subject design for comparison. Patients first complete informed consent and baseline questionnaires and are placed on a waiting list for five weeks. After this period, they are reassigned to the active (experimental) group, which will receive five sessions of exposure therapy in virtual reality over a subsequent five-week period. The treatment effect will be evaluated using pre/post assessments, as well as monitoring adherence to exposure and response prevention assignments.

This description comes directly from the study's public registry record.

Talk to the study team

Iveta Hocko Fajnerová  ·  +420608501034  ·  iveta.fajnerova@nudz.cz

Pavla Stopková  ·  pavla.stopkova@nudz.cz

Always discuss trial participation with your own doctor first.

Locations (1)

Nationa Institute of Mental HealthKlecany, Česká Republika, CzechiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07206199